HSA
JAZZ icon

Hussman Strategic Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Hussman Strategic Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$794K Buy
+4,200
New +$734K 0.17% 212
2025
Q3 		– Sell
-21,000
Closed -$2.23M – 312
2025
Q2 		$2.23M Buy
+21,000
New +$2.28M 0.51% 78
2023
Q2 		– Sell
-12,400
Closed -$1.81M – 318
2023
Q1 		$1.81M Hold
12,400
– – 0.28% 141
2022
Q4 		$1.98M Hold
12,400
– – 0.32% 123
2022
Q3 		$1.65M Buy
12,400
+2,000
+19% +$304K 0.29% 142
2022
Q2 		$1.62M Buy
10,400
+5,200
+100% +$800K 0.28% 136
2022
Q1 		$809K Sell
5,200
-10,400
-67% -$1.51M 0.16% 203
2021
Q4 		$1.99M Sell
15,600
-9,200
-37% -$1.21M 0.44% 85
2021
Q3 		$3.23M Buy
24,800
+3,200
+15% +$483K 0.71% 25
2021
Q2 		$3.84M Hold
21,600
– – 0.79% 15
2021
Q1 		$3.55M Buy
21,600
+1,100
+5% +$181K 0.73% 22
2020
Q4 		$3.38M Buy
20,500
+250
+1% +$37.2K 0.89% 7
2020
Q3 		$2.89M Hold
20,250
– – 0.76% 24
2020
Q2 		$2.23M Buy
20,250
+5,000
+33% +$553K 0.57% 61
2020
Q1 		$1.52M Buy
15,250
+10,250
+205% +$1.33M 0.41% 91
2019
Q4 		$746K Buy
+5,000
New +$680K 0.24% 148
2019
Q2 		– Sell
-400
Closed -$57K – 220
2019
Q1 		$57K Sell
400
-20,000
-98% -$2.61M 0.01% 224
2018
Q4 		$2.53M Buy
+20,400
New +$3.03M 0.61% 58
2018
Q1 		– Sell
-25,000
Closed -$3.37M – 232
2017
Q4 		$3.37M Buy
+25,000
New +$3.47M 0.96% 40

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Hussman Strategic Advisors's JAZZ Position: Q1 2026 in Review

Hussman Strategic Advisors opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 4,200 shares worth $794K. The stake represents 0.17% of the portfolio and ranks #212 among its holdings. This is a return to the name: Hussman Strategic Advisors previously reported a position in JAZZ as recently as Q2 2025.

Hussman Strategic Advisors first reported a position in JAZZ in Q4 2017 and has held it in 19 quarters since. The position peaked at $3.84M in Q2 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Hussman Strategic Advisors held 4,200 shares of Jazz Pharmaceuticals worth $794K as of Q1 2026.
  • Jazz Pharmaceuticals was a new Hussman Strategic Advisors position in Q1 2026.
  • Jazz Pharmaceuticals made up 0.17% of Hussman Strategic Advisors's portfolio in Q1 2026, its #212 holding.
  • Hussman Strategic Advisors first reported a position in Jazz Pharmaceuticals in Q4 2017 and has held it in 19 quarters since.
  • Hussman Strategic Advisors's Jazz Pharmaceuticals position peaked at $3.84M in Q2 2021.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Hussman Strategic Advisors's 13F filing for Q1 2026, filed 11 May 2026.